Medical questions 3 Flashcards

1
Q

What are the causes of Parkinsonism?

A
Idiopathic Parkinson's disease
Drugs (dopamine antagonists) - chlorpromazine, metoclopramide, prochlorperazine
Tumours of the basal ganglia
Lewy body dementia
Dementia pugilistica
Normal pressure hydrocephalus
Parkinson Plus syndromes: multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration
Post encephalitis
Wilson's disease
Toxins e.g. MPTP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What do you understand by the term Parkinson’s disease?

A

PD is a neurodegenerative disorder caused by the disruption of dopaminergic neurotransmission in the basal ganglia. Histologically, there is a loss of melanin-containing dopaminergic neurons in the substantia nigra and cytoplasmic inclusions called Lewy bodies in the surviving dopaminergic neurons. Approximately 60-80% of dopaminergic neurons are lost before the motor signs of PD emerge.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do you distinguish dementia and dementia with Lewy bodies?

A

Dementia usually occurs late in PD and affects 15-30% of patients. Cognitive symptoms that occur earlier, i.e. within a year of onset of motor symptoms would suggest a diagnosis of Lewy body dementia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the characteristics of multiple systems atrophy?

A

Characterised by varying degrees of Parkinsonism, autonomic failure, cerebellar dysfunction and pyramidal signs.

When Parkinsonian features are prominent, it is termed MSA-P. When cerebellar signs are prominent, it is termed MSA-C. When autonomic dysfunction is prominent, it is termed Shy-Drager syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the characteristic features of progressive supranuclear palsy?

A

This is the commonest Parkinson Plus syndrome. There is involvement of multiple neurotransmitter pathways.

Supranuclear gaze palsy manifests as abnormal vertical, then horizontal saccades. Other features include difficulty opening the eyes, early and prominent falls, speech and swallowing difficulties and frontal symptoms including depression, apathy and cognitive impairment.

Compared to PD, the parkinsonian features are symmetrical and axial rigidity is more prominent than limb. Tremor is less common. There is often a poor response to L-dopa. Progression is rapid, with survival from onset of 5-7 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the characteristics of corticobasal degeneration?

A

Characterised by frontoparietal cortical atrophy in addition to degeneration in the extrapyramidal system. Presents with atypical Parkinsonian features and associated higher cortical abnormalities including limb apraxia and cortical sensory loss. “Alien limb”. Myoclonus can also occur and dementia may develop later in the disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How would you distinguish the tremor in Parkinson’s from essential tremor?

A

Essential tremor is usually symmetrical and made worse with voluntary movement. It is often accompanied by a voice and head tremor, whereas in Parkinsonism, the tremor does not affect the head. About 50% of patients with Parkinsonism also have a postural component, but on asking the patient to write, PD patients display micrographia, whereas in ET, the script becomes larger and irregular.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How would you manage psychosis associated with anti-Parkinsonian drugs?

A

Clozapine is the best agent, although other agents such as quetiapine and olanzapine may be effect. Risperidone can exacerbate parkinsonism and should be avoided.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What surgical therapies are available for Parkinson’s disease?

A

Thalotomy
Pallidotomy
subthalamotomy
Deep brain stimulation has replaced lesion surgeries and does not involve a permanent lesion to the brain, making it reversible.
Transplantation is a potential treatment for PD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is motor neuron disease?

A

Motor neuron disease is a progressive disorder characterised by neuronal loss at all levels of the motor system from the cortex to the brainstem and anterior horn cells of the spinal cord. Physical signs therefore include both upper and lower motor neuron signs. There are different forms of motor neuron disease:

  • Amyotrophic lateral sclerosis - both upper and lower motor neuron signs
  • Progressive muscular atrophy - predominant lower motor neuron signs
  • Primary lateral sclerosis - predominant upper motor neuron signs
  • Progressive bulbar palsy - predominantly bulbar involvement (can be bulbar or pseudobulbar)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which diseases may mimic motor neuron disease?

A

UMN and LMN presentation:

  • Syringomyelia (often presents with LMN signs in arms and UMN signs in the legs).
  • Cervical myelopathy and co-existent peripheral neuropathy (dual pathology)
  • Multifocal motor neuropathy with conduction block
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How would you manage a patient with MND?

A

MDT approach and should be guided by respect for autonomy and choice, symptom control and quality of life and palliative care.

Symptoms requiring treatment include:
Drooling - anticholinergics, TCAs, hyoscine patches
Dysphagia - consider PEG tube
Communication difficulties - SALT
Emotional liability - amitriptyline, lithium, L-DOPA
Fasciulations - magnesium, quinine, anti-epileptics
Spasticity - physiotheraphy and drugs e.g. baclofen
Limb weakness - splints, supports, physiotherapy
Respiratory symptoms - consider non-invasive support
Depression - antidepressants
Pain - analgesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Do you know of any disease modifying treatments for MND?

A

Riluzole is the only licenced drug. It does not improve symptoms or prevent death, but RCTs suggest a 3 month increased survival over an 18 month trial period.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the common causes of cerebellar syndrome?

A

Demyelination (MS)
Alcoholic cerebellar degeneration
Posterior fossa space occupying lesions
Brainstem lesions
Drugs e.g. lithium, phenytoin, carbamazepine, phenobarbitone, chemotherapy
Hereditary e.g. Friedreich’s ataxia, ataxia telangiectasia
Hypothyroidism
Paraneoplastic (anti-Yo - gynaecological and breast ca, and anti-Hu antibodies - small cell carcinoma of the lung, prostate ca, sarcomas and neuroblastomas)
MSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the genetic basis of myotonic dystrophy?

A

It is an autosomal dominant disease caused by a CTG triplet expansion in the myotonin protein kinase gene on chromosome 19, repeated up to 2000 times (normally 5036). It demonstrates expansion and anticipation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the common causes of a sensorimotor polyneuropathy?

A
Alcohol
Diabetes
Hypothyroidism
Uraemia
Sarcoiditis
Vasculitis
Paraneoplastic
Chronic inflammatory demyelinating polyneuropathy/Guillain-Barre syndrome
Hereditary motor and sensory neuropathies
17
Q

What are the causes of an autonomic neuropathy?

A
Guillain-Barre
Botulism
Porphyria
Paraneoplastic
Diabetes
Chagas disease
HIV
Amyloidosis
18
Q

What are the causes of mononeuritis multiplex?

A
Diabetes
Vasculitis: polyarteritis nodosa, Churg-Strauss, Wegener's
Inflammatory: Rheumatoid, SLE, Sjogren's
Sarcoidosis
Lympoma
Amylodosis
Infectious: Lyme disease, leprosy
19
Q

How would you investigate a patient with peripheral neuropathy?

A

Blood tests: FBC, ESR, U&E, LFT, glucose, TFTs, serum B12 and folate, serum protein electrophoresis, autoimmune profile

Urine: glucose, Bence-Jones protein

other tests: nerve conduction studies, CSF analysis, autonomic function tests, nerve biopsy, genetic testing

20
Q

What is the pathophysiology of multiple sclerosis?

A

MS is an idiopathic demyelinating disorder of the CNS, characterised by demyelinating plaques both separated in space and time. It is regarded as an autoimmune disease. What triggers it is unclear. Acute MS plaques develop when primed T-lymphocytes cross the blood brain barrier and activate macrophages, resulting in demyelination. The axons lose their ability for saltatory conduction and inflammatory mediators further impede axonal conduction.

21
Q

What is Lhermitte’s sign?

A

Neck flexion results in rapid tingling or an electric shock-like feeling passing down the spine into the arms and legs. It indicates dorsal column involvement of the cervical spinal cord. Causes include MS, cervical myelopathy, cervical cord tumour, subacute degeneration of the cord.

22
Q

What is Uhtoff’s phenomenon?

A

A raised body temperature results in exacerbation of symptoms.

23
Q

What is internuclear ophthalmoplegia?

A

The medial longitudinal fasciculus connects the ipsilateral III nucleus (medial rectus) with the contralateral VI (lateral rectus) nucleus and is involved in the control of conjugate eye movement. A lesion in the MLF primarily results in impairment of ipsilateral adduction. With normal abduction of the contralateral eye, there will be a divergence, thus the abducting eye flicks back towards the nose to correct for this and continued abduction - nystagmus in the contralateral eye. Causes:

  • MS
  • Brainstem lesions
  • Wernicke’s encephalopathy
  • SLE
  • Miller Fisher syndrome
  • Drug overdose e.g. TCA, phenytoin and barbiturates
24
Q

What investigation is most useful for confirming the diagnosis of MS?

A

MRI

25
Q

What treatments are available for MS?

A

General measures: patient education, physio, OT, walking aids and visual aids

Acute attacks: IV methylpred, plasma exchange

Disease modifying therapies: interferon-beta, glatirimir acetate, mitoxantrone, natalizumab

Symptomatic treatment:

  • Spasticity: baclofen
  • Depression: antidepressants
  • Fatigue: amantidine, modafinil
  • Pain: carbamazepine, TCAs
  • Bladder dysfunction: self-intermittent catherisation, anti-cholinergics
  • Sexual dysfunctioning: counselling
  • Erectile dysfunctioning: sildenafil
26
Q

What are the causes of splenomegaly?

A

Massive (>8cm) - myeloproliferative disorders (CML and myelofibrosis), tropical infections (malaria and visceral leishmaniasis)

Moderate (4-8cm) - myeloproliferative disorders, infiltration (Gaucher’s and amyloidosis)

Mild (<4cm) - myeloproliferative disorders, portal hypertension, infections (EBV, IE and infective hepatitis), haemolytic anaemia

27
Q

What are the indications for splenectomy?

A

Rupture (trauma)

Haematological (ITP and hereditary spherocytosis)

28
Q

What are the causes of renal enlargement?

A

Unilateral: PKD, renal cell carcinoma, simple cysts, hydronephrosis

Bilateral: PKD, bilateral renal cell carcinoma, bilateral hydronephrosis, tuberous sclerosis (renal angiomyolipomata and cysts), amyloidosis

29
Q

What evidence of immunosuppression may be visible?

A

Ciclosporin: gum hypertrophy and hypertension
Steroids: cushingoid appearance

Skin: malignancy - actinic keratoses, SCC and BCC

Infection: viral warts, cellulitis